News
GEVELOT S.A.: Number of Shares and Voting rights 4 January 2024
ABIONYX Pharma appoints Rob Scott, MD, as Chief Medical Officer and Head of R&D
ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a next-generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only recombinant
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31
EQS-News: Abivax 2024 Financial Communication Calendar
Poxel Announces its Financial Calendar for 2024
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
ROCTOOL: Proposed entry of ENRX into the capital of ROCTOOL
Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan
Regulatory News:
Median Technologies (Paris:ALMDT) announces that it has received approval from the European Investment Bank to draw down the final tranche of the loan granted on December 18
Poxel Provides Corporate Update
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Transgene Announces Upcoming Investor Meetings
Regulatory News:
TRANSGENE (Paris:TNG) today announces that Management will participate in several investor events in the upcoming investor events, as set out below.
Transgene will meet
Prodware: Prodware steps up its expansion in Europe with the acquisition of Nut Consulting in Spain
Sensorion Publishes Results of Combined General Meeting Resolutions
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
FOCUS ENTERTAINMENT: Geoffroy Sardin's Appointment as Deputy CEO of Focus Entertainment
FOCUS ENTERTAINMENT: Creation of Scripteam and acquisition of stakes in two studios to build an audiovisual platform
Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
Regulatory News:
Median Technologies (Paris:ALMDT) and PASREL-Imagerie, announce today the signing of an agreement to deliver cutting-edge imaging biomarkers for the development of new oncology
FOCUS ENTERTAINMENT: H1 2023/2024 results : strong growth in revenue and lower profitability
Dassault Aviation and Dassault Systèmes Extend Collaboration to Aircraft Maintenance, Repair and Overhaul in the Cloud
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Dassault Aviation has extended its use of the 3DEXPERIENCE platform on a sovereign cloud to optimize the maintenance
RALLYE S.A.: Appeal against the decision of the Sanctions Commission of the French Financial Market Authority
Eutelsat OneWeb signs multi-million dollar exclusive distribution agreement with Rawafed Libya to deliver connectivity services across Libya.
Regulatory News:
Eutelsat Group (Paris:ETL) (LSE:ETL), the world’s first GEO-LEO satellite operator, has today announced the signing of an exclusive distribution partnership agreement between
Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Officer
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
FOCUS ENTERTAINMENT: Announces, at the Game Awards, the release date of WARHAMMER 40,000: SPACE MARINE 2 on September 9th, 2024 - A new impactful trailer for Banishers : Ghosts of New Eden
Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the